- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06517238
A New Digital Communication Tool Between Dentist and Orthodontist to Improve Dental Prevention (ComDentODFPrev)
Development and Evaluation of a New Digital Communication Tool Between Dentists and Orthodontists to Improve Oral Prevention for Patients With Multi-bracket Treatment
Dentists and orthodontists of the oral medicine department of Reims University Hospital noted that many children presented white spots around orthodontic brackets, or decays at the end of their multi-brackets orthodontic treatment. These defects required dental cares and sometimes led to dental avulsions. These situations highlighted a poor oral hygiene of children (poorly done or insufficient dental brushing), a lack of oral prevention of their dentist and/or orthodontist, or even a lack of communication between these two practitioners.
The objective of this study is to evaluate if a regular prevention and a specific communication between dentist and orthodontists could reduce the individual caries-risk of patients with multi-brackets orthodontic treatment. During all the orthodontic treatment, a semi-annual oral prevention consultation will be established for each patient, and a digital communication tool will be made available to dentists and orthodontists to facilitate their exchanges.
The study population consists of children under 18 years-old when laying multi-brackets orthodontic treatment.
The study population consists of children aged 8 to 18 years-old (at the start of treatment) treated with multi-brackets orthodontic treatment. The study population is divided in two groups: (i) a control group corresponding to children not benefiting from regular oral preventive follow up monitoring and completing their orthodontic treatment during the year in 2024; (ii) a study group composed of children starting their orthodontic treatment during the year in 2024 and benefiting from regular oral prevention every 6 months, up to four years.
Several parameters will be evaluated from patient medical records: the caries index, the ICDAS score, the plaque index, the oral hygiene and food habits. Concerning the study group, a new digital communication tool will be made available to the dentist and the orthodontist to monitor the oral hygiene of patients. An evaluation of the oral hygiene will be done every 6 months.
The expected outcomes of this study concern the interest of (i) a bi-annual prevention consultation to reduce caries risk, (ii) a regular communication between practitioners to adjust the orthodontic treatment according to the individual caries-risk.
The expected hypothesis is to decrease the patient's caries and plaque indexes in the study group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study population consists of children under 18 years-old when laying multi-brackets orthodontic treatment in the oral medicine department of Reims University Hospital. This population is distributed into 2 groups. The control group consists in children having completed their orthodontic treatment by December 2024, (n=30). The study group consists in children starting their orthodontic treatment during 2024 and benefiting from semi-annual oral prevention during four years-treatment. Moreover, their dentists and orthodontists will be able to access a digital communication tool to facilitate their exchanges. The number of patients in the study group will depend on the number of the patients in the control group.
The study protocol was approved by a regulatory agreement of the RGPD (register of processing activities) of Reims University Hospital since 14/11/23. All data will be anonymized. These data correspond to those that are systematically and usually collected by professionals during the orthodontic treatment. They will be stored in a secure computer located in the oral medicine department. The aim of the study and clinical procedures will be explained to the parents and the children to obtain their informed consent.
Data collected for control group at the treatment completion, an average of 4 years: put out the treatment:
- Sex: Girl/Boy/Non-Registered
- Date of birth (month/year) / age
- Processing end date
- Regular orthodontic appointment
- Socio-Professional Category (PCS 2020 level 1 nomenclature: 6 levels INSEE) : farmers; artisans, traders and business leaders; executives and higher intellectual professions; intermediate professions ; employees ; workers
- Decayed, missing and filled teeth index (DMFT Index)
- ICDAS score (International Caries Detection and Assessment System)
- Decays under dental restauration
- Modified orthodontic plaque index (MOP Index)
Individual carious risk (based on HAS-France):
- Regular brushing
- Manual or electric brushing
- Presence of snacking and soda
- Taking long-term sweet or medication causing hyposialia
- Presence of dental plaque visualized by dental plaque disclosing tablet
- Presence of dental plaque visible without dental plaque disclosing tablet
- Presence of enamel demineralization
- Presence of caries lesions (dentin involvement) and/or reversible initial lesions (enamel involvement)
- Serrated grooves in molars
- Grooves treated by Sealent
- Fluoride varnish
- Presence of gingival hyperplasia
Data collected for study group during each consultation before the orthodontic treatment and followed every 6 months, up to 4 years:
- Appointment date
- Sex: Girl/Boy/Non-Registered
- Date of birth (month/year) / age
- Regular follow-up with a dentist
- Socio-Professional Category (PCS 2020 level 1 nomenclature: 6 levels INSEE) : farmers; artisans, traders and business leaders; executives and higher intellectual professions; intermediate professions ; employees ; workers
- Decayed, missing and filled teeth index (DMFT Index)
- ICDAS score (International Caries Detection and Assessment System)
- Plaque Index Silness et Loe before treatment
- Modified orthodontic plaque index (MOP Index) as soon as the treatment is applied
- Molar Incisor Hypomineralization (MIH): degree of severity (moderate - severe), type of teeth affected (molars - incisors), number of teeth treated
- Amelar abnormality: incisal dysplasia, number of teeth treated
Individual carious risk (based on HAS-France):
- Regular brushing
- Manual or electric brushing
- Presence of snacking and soda
- Taking long-term sweet or medication causing hyposialia
- Presence of dental plaque visualized by dental plaque disclosing tablet
- Presence of dental plaque visible without dental plaque disclosing tablet
- Presence of enamel demineralization
- Presence of caries lesions (dentin involvement) and/or reversible initial lesions (enamel involvement)
- Serrated grooves in molars
- Grooves treated by Sealent
- Fluoride varnish
- Presence of gingival hyperplasia
- Need for prevention and/or care sessions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Charline GUIDEZ
- Phone Number: 0033 03 26 78 77 11
- Email: cguidez@chu-reims.fr
Study Locations
-
-
-
Reims, France
- Recruiting
- Damien JOLLY
-
Contact:
- Charline GUIDEZ
- Phone Number: 0033 03 26 78 77 11
- Email: cguidez@chu-reims.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria:
Patients aged under 18 years old when laying treatment. They required multi-brackets orthodontic treatment in the oral medicine department of the Reims University Hospital
Exclusion criteria:
- children under 8 years old
- Patients requiring other orthodontic treatment than multi-brackets,
- Patients requiring any orthodontic treatment
- disabled (with a loss of autonomy that don't allow proper brushing)
- dental pathologies like amelogenesis imperfect, dentinogenesis imperfect, ectodermal dysplasia.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Control group
|
Observal Study.There is no intervention
|
|
Study group
Children starting a multi-brackets orthodontic treatment in the oral medicine department of University Hospital of Reims from January 2024.
These childrens benefit from semi-annual appointment to analyze their oral health and their individual caries-risk by dentist.
Moreover, these results will be communicated with a digital tool to orthodontist who can choose to adapt the orthodontic treatment of these childrens.
|
Observal Study.There is no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of DMFT index
Time Frame: every 6 months, up to 4 years
|
Number of Decayed, Missing due to caries, and Filled Teeth
|
every 6 months, up to 4 years
|
|
Measure of plaque index (Silness and Loe)
Time Frame: every 6 months, up to 4 years
|
|
every 6 months, up to 4 years
|
|
Modified Orthodontic Plaque index (MOP)
Time Frame: every 6 months, up to 4 years
|
|
every 6 months, up to 4 years
|
|
Measure of ICDAS score
Time Frame: every 6 months, up to 4 years
|
|
every 6 months, up to 4 years
|
|
Socio-Professional Category
Time Frame: Day 1
|
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communication needed between dentist and orthodontist
Time Frame: At 48 months
|
focus group of dentist and orthodontist at the beginning and at the end of the study
|
At 48 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023Ao001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on There is no intervention
-
University of PennsylvaniaNovo Nordisk A/S; Albert Einstein College of Medicine; Northwestern University; Yale University and other collaboratorsRecruitingDiabetic Nephropathies | Diabetic GlomerulosclerosisUnited States
-
Göteborg UniversityNot yet recruitingCritical Illness | End of Life Care | Ethics
-
Peking University Third HospitalNot yet recruitingTransfusion-Associated Intestinal Injury,Ultrasound,Near-Infrared Spectroscopy
-
Leiden University Medical CenterHamilton Medical AGRecruitingCritical Illness | Intensive Care Unit | Mechanical VentilationNetherlands
-
University of California, San FranciscoRecruitingMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI | Wolman Disease | Pompe Disease Infantile-Onset | Mucopolysaccharidosis IV A | Mucopolysaccharidosis VII | Neuronopathic Gaucher DiseaseUnited States
-
Beaujon HospitalCompletedContrast-associated Acute Kidney InjuryFrance
-
Linkoeping UniversityCompleted
-
Stanford UniversityDuke University; National Institute of Environmental Health Sciences (NIEHS)CompletedPregnancy | Air PollutionUnited States
-
Northwell HealthWinterlight LabsCompletedSchizophrenia and Related DisordersUnited States
-
Danish Headache CenterCompletedMigraine | HeadacheDenmark